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The aim of this work was to describe the results of a simple quality control procedure for the flow–volume curve
adopted in a multicentre epidemiological study (PEACE).
In 14 centres, 8–15 individuals (n=157) performed forced vital capacity (FVC) manoeuvres following a standard
protocol with both the local spirometer/pneumotachograph and a portable spirometer (i.e. the ‘reference
instrument’ for this study). Deviances of measurements were assessed by computing the dierences (D) between the
former and the latter, the ratios of such dierences on portable spirometer values (D%) and the coecients of
variation (CV).
The portable spirometer yielded lower mean DFVC and DFEV1 (forced in 1 sec) than local instruments (except
for two and four centres, respectively). In most instances, dierences were statistically significant. Absolute mean
%FVC ranged from 49–182%, while D%FEV1 ranged from 23–185%. The Bland and Altman analysis showed
a good agreement between the portable and local instruments, except for two centres, where a systematic trend
towards higher individual absolute DFVC and DFEV1 was observed. The overall variability, assessed by CV, was
within 62% and 51% for FVC and FEV1, respectively: it was similar to other quality control studies ranging from
20–55% for FVC and 22–58% for FEV1.
Our results point out the importance of performing interlaboratory comparisons as a quality control procedure
in multicentre epidemiological studies on lung function, and of stimulating manufacturers to extend the accuracy
and precision of the instruments.
Key words: multicentre panel study; flow–volume curve, spirometer; pneumotachograph; PEACE; inter-laboratory
variability.
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The importance of spirometry standardization has been
recently reinforced in Europe (1) and the U.S.A. (2).
Although international guidelines have existed for many
years (3–4), recent studies have shown the persistence of an
elevated interlaboratory variability (5–6).
However, multicentre lung function studies have demon-
strated the possibility of reducing such variability by
observing a strictly standardized protocol (7–8). Within
the framework of the Commission of the European
Communities Concerted Action on Air Pollution Epide-
miology (9–11), the idea came of implementing a# 2000 HARCOURT PUBLISHERS LTD
QUALITY CONTROL BY FLOW–VOLUME CURVE MEASUREMENTS 195collaborative study in order to develop a standardized
methodology for panel studies on the eects of short-term
changes in air pollution on the respiratory system. The
study was then approved and funded by the Environment
Research Programme of the Commission of the European
Communities.
The PEACE study (acronym for Pollution Eects on
Asthmatic Children in Europe) is a study of the acute
health eects of short-term changes in air pollution on
children with chronic respiratory symptoms (12). It was
conducted in the winter of 1993–94 following a standar-
dized protocol by 14 research centres in Europe. The target
was children of primary school age, 6–11 years old, who
had experienced chronic respiratory symptoms in the year
preceding the study or had ever been told by a doctor that
they had asthma. Forced expiratory manoeuvres were used
for further subject characterization in order to evaluate the
extent to which forced expiratory flows and volumes are
related to a subject’s response to air pollution.
The aim of this work was to describe the results of a
simple quality control procedure adopted in the PEACE
study, based on the comparison of instruments used for
flow–volume curve measurements in the various centres
with a portable spirometer, during the site visits by one of
the members of the co-ordinating centre.
Material and methods
Fourteen research centres of 10 European countries
participated in the PEACE study: five from four dierent
EC member states (Germany, Greece, Italy, The Nether-
lands), five from Central or Eastern European Countries
(Czech Republic, Hungary, Poland) and four from Scandi-
navian Countries (Finland, Norway, Sweden).
The protocol of the study has been fully described
elsewhere (12). Briefly, two groups of about 75 children,
with chronic respiratory symptoms or medical diagnosis of
asthma were selected from the general population of
primary school age, 6–11 years old, with a screening
questionnaire. Children from the two groups were followed
for about 2 months: they recorded peak expiratory flow
(PEF) with a Mini-Wright peak flow meter twice a day and
their parents filled in a daily questionnaire to collect
information on children’s respiratory symptoms and daily
activity patterns. Children lived either in an urban or in a
suburban or rural area, where ambient air pollutants (SO2,
NO2, NO, PM10, Black Smoke) were measured on a daily
basis.
For further subject characterization, evaluation of
pulmonary function using forced expiratory manoeuvres
was included. The protocol proposed for pulmonary
function testing (13) was developed by the European
Community for Coal and Steel (ECCS) (3). In the
proposed protocol some modifications were made, accord-
ing to the update of the ECCS (1). The instruments and
software for data acquisition had to fulfill the technical
requirements of the ECCS (1, 3). As pulmonary function
testing originally was not part of the PEACE core
protocol, each centre used its own equipment (spirometeror pneumotachograph). The temperature of the room had
to be noted to allow the correction of measurements to
BTPS (body temperature, ambient pressure, saturated with
water vapour). Calibration of volume measurement was
performed daily prior to testing and then every 4 h during
use by a calibrated syringe with a volume of at least 3 l.
Manoeuvres of forced expiration had to be performed in
the sitting position, whilst wearing a nose-clip. Subjects
had to perform up to eight attempts and technically
acceptable manoeuvres according to ECCS criteria had to
be recorded. Subjects who were unable to produce three
acceptable manoeuvres after eight attempts had to be
excluded from analyses. The largest and the second largest
forced vital capacity (FVC) and forced expiratory volume
in 1 sec (FEV1) should not vary by more than 5% or
100 ml, whichever is greater. The highest values of FVC
and FEV1 (in l) had to be selected from all acceptable
curves and used in statistical analyses.
In the protocol for pulmonary function testing (13) use of
the reference equations of Zapletal (14) was proposed to
assess lung function of the children. In case Zapletal’s
reference equations had a poor fit, the centre could decide
to determine reference equations based on its own
population.
In order to document possible dierences in equipment
for pulmonary function measurements used in the various
centres, forced expirograms were performed using a
portable spirometer (Micro Medical Microlab 3300, Micro
Medical Ltd, Rochester, U.K.) during site visits before the
start of field survey.
In each centre, 8–15 dierent individuals performed
forced expiratory manoeuvres according to the protocol
used in the PEACE study on both the portable spirometer
and the spirometer/pneumotachograph used by the local
centre. In each centre half of the subjects were first tested
with the portable spirometer and the other half with the
local instrument. One test with one instrument was
immediately followed by the other test using the other
instrument. Between September 1993 and June 1994, the
test of the instruments in the various centres was performed
in the following order: Athens, Cracow, Prague, Budapest,
Hettstedt, Berlin, Umea˚, Katowice, Amsterdam, Teplice,
Pisa, Oslo, Kuopio, Malmo¨.
Deviances of FVC and FEV1 were computed both as
dierences of observed values between the local spirometer/
pneumotachograph and the portable spirometer (D) and as
ratios of such dierences on portable spirometer values
(D%). Consequently, negative values referred to those
situations in which portable spirometer yielded higher FVC
or FEV1 values.
Further, between-instrument variability was computed
using the coecient of variation (CV) according to Wise et
al. (16), applied as follows:
CV 

1
n
Xn
i1
Q2i
s
where Qi 

2
p S1i ÿ S2i
S1i  S2i
and S1i and S2i are the individual’s spirometry values for
the S1 measurement (by local instrument) and the S2
measurement (by portable spirometer), respectively.
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Centre of the University of Ferrara (CINECA) by using the
routines of the Statistical Package for the Social Sciences
(SPSS/PC+Update for v30 and 31, Chicago 1989,
U.S.A.). The ‘non parametric’ Friedman test and the
analysis of variance (ANOVA)—accounting for covariates
such as sex, age and height—were performed to test
dierences between measurements by local and portable
instruments within each centre, whilst comparisons among
dierences in spirometry measurements obtained in the
various centres were performed by the analysis of variance
(ONEWAY) with its subroutine Duncan’s range test.
Regression analyses were run to test correlation between
measurements by local and portable instruments within
each centre. Agreement between measurements by local and
portable instruments within each centre was also evaluated
by using the Bland and Altman analysis (15).
Results
With the exception of Cracow, Hettstedt and parts of Oslo,
all the centres investigated an adult population (Table 1).
Overall, 157 subjects, well balanced by gender, participated
in the study: on average, each centre examined 112 people,
with a minimum of eight in Umea˚ and a maximum of 15 in
Malmo¨.
Mean DFVC for all PEACE centres was 018 l, ranging
from 7052 l in Budapest to 087 l in Pisa (Table 2). In
general, the portable spirometer yielded lower mean values
of FVC than local spirometer/pneumotachograph, except
for Budapest and Cracow. In most instances, dierencesTABLE 1. Characteristics of subjects tested by local and portab
Laboratory Instrument M F Total M
Amsterdam S 3 7 10 3
Athens P 5 6 11 3
Berlin P 4 7 11 4
Budapest S 6 4 10 3
Cracow S 11 — 11 1
Hettstedt (1) P 8 6 14 1
Katowice P 7 3 10 2
Kuopio P 5 8 13 3
Malmo¨ S 8 7 15 4
Oslo(2) P 7 2 9 2
Pisa P 8 4 12 3
Prague P 3 7 10 3
Teplice S 2 11 13 3
Umea˚ P 4 4 8 4
All — 81 76 157 3
P: pneumotachograph; S: spirometer.
(1) Composite population, 13 children  12 years of age and on
(2) Composite population, four children  13 years of age andwere found to be statistically significant by the Friedman
test. When ANOVA was employed, accounting for sex, age
and height, only five centres (Athens, Cracow, Hettstedt,
Pisa and Prague) still showed significant dierences
between the local and the portable instrument. The range
of FVC values measured on the participating subjects in the
dierent centres was quite large: from 165 l in Hettstedt to
640 l in Amsterdam for local instrument; from 155 l in
Hettstedt to 625 l in Kuopio for portable spirometer.
Figure 1 shows the agreement for FVC between the
portable spirometer and the local instruments. The upper
and lower limits of agreement (defined as the mean DFVC
for all PEACE centres plus or minus two standard
deviations of DFVC) were 106 and 7070 l, respectively.
Most of the DFVC observed in the various PEACE centres
fell within such limits, with the exception of Budapest (two
observations), Oslo (one observation) and Pisa (three
observations).
Further, for all PEACE centres a highly significant
coecient of correlation between FVC values of local and
portable spirometer was observed: it ranged from 078 to
098 and was  092 in 11 centres.
Absolute mean values of D%FVC were comprised of
between 49% in Amsterdam and Malmo¨ and 182% in
Pisa (Fig. 2).
By Duncan’s range test, mean DFVC in Budapest was
significantly larger than mean DFVCs in Malmo¨ and
Kuopio, while Pisa showed a significantly larger value than
those of all other centres.
Mean DFEV1 for all PEACE centres was 010 l, ranging
from 7055 l in Budapest to 075 l in Pisa (Table 3). Also
for FEV1 the portable spirometer gave lower mean valuesle instrument in PEACE study centres
Age (years) Height (cm)
ean SD Range Mean SD Range
14 71 24–45 1754 67 168–188
49 101 23–53 1707 81 160–181
33 86 26–54 1731 75 165–190
92 93 23–52 1723 80 160–183
02 15 8–12 1375 71 126–151
04 89 7–41 1378 126 124–170
89 60 20–40 1735 53 165–180
35 92 24–53 1723 83 161–187
25 131 21–60 1723 88 160–183
54 171 9–60 1588 182 137–183
17 43 26–40 1742 66 162–188
93 120 22–59 1698 90 150–180
85 86 22–53 1668 72 158–186
13 98 26–53 1723 106 160–190
20 141 7–60 1658 156 124–190
e adult.
five adults.
TABLE 2. Mean values of FVC (l) measured by local and portable instrument in PEACE study centres, and mean values of
the dierence (D) (l) between the observed values
Local Portable D
Laboratory n Mean SD Mean SD Mean SD P(1) P(2)
Amsterdam 10 515 067 497 059 024 018 006 050
Athens 11 454 071 415 072 038 023 50001 004
Berlin 11 467 092 453 082 024 015 037 056
Budapest 10 394 100 441 091 7052 059 001 010
Cracow 11 223 031 257 035 7034 017 50001 0009
Hettstedt 14 253 063 234 047 026 025 0002 004
Katowice 10 458 098 432 109 028 021 006 036
Kuopio 13 464 109 452 113 022 027 041 045
Malmo¨ 15 451 089 449 097 022 021 044 092
Oslo(3) 10 343 122 312 119 039 035 001 011
Pisa 12 572 099 484 083 087 041 50001 50001
Prague 10 449 074 417 067 032 014 001 005
Teplice 13 403 079 384 076 029 027 003 034
Umea˚ 8 454 095 426 110 031 021 048 011
All 158 419 125 403 114 018 044 50001 0005
(1)By Friedman test.
(2)By ANOVA, accounting for sex, age, height (in Cracow only for age and height, since all subjects were males).
(3)One subject in Oslo has missing data for age, height and sex.
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exceptions (Budapest, Cracow, Kuopio and Umea˚). Ten
out of 14 comparisons reached a significance level by
Friedman test, but only three by ANOVA (Cracow,
Hettstedt, Pisa). The range of FEV1 values measured in
the participating subjects from the various centres showed a
trend similar to that of FVC: from 144 l in Cracow to 629 l
in Pisa for the local instrument and from 139 in Oslo to
544 l in Katowice for the portable spirometer.
For FEV1 most of the dierences between the portable
spirometer and the local instruments fell within the limits of
agreement (i.e. between 078 and 7058 l), with the
exception of Budapest (two observations), Pisa (six
observations) and Prague (one observation) (Fig. 3).
Further, all centres, with the exception of Budapest,
showed a highly significant coecient of correlation for
FEV1 between the local and portable spirometers: it ranged
from 077 to 10 and was  098 in nine centres.
Absolute mean D%FEV1 was found to be between 23%
in Malmo¨ and 185% in Pisa (Fig. 4).
Mean DFEV1 in Budapest and in Pisa was significantly
larger than those of all other centres. In addition, mean
FEV1 in Prague was significantly larger than in Kuopio,
Malmo¨ and Teplice.
Table 4 shows the CV of FVC and FEV1 measured by
local and portable instruments. In all centres, a mean CV
value of 62% and 51% was observed for FVC and FEV1,
respectively. In particular, the largest CV values were
observed in Cracow for FVC (100%), in Budapest for
FEV1 (115%), and in Pisa for both spirometric indices(116% and 119%, respectively). Excluding the few centres
with statistically significant DFVC and DFEV1 values, as
reported in Tables 2 and 3, a mean CV of 51% for FVC
and of 39% for FEV1 was obtained.
Discussion
Our findings emphasize the importance of performing
comparisons among pulmonary function laboratories as
quality control procedures in the framework of multicentre
studies. In fact, although the recommended standards (1–4)
have been successful in improving precision and accuracy of
most modern instruments, a not negligible between-instru-
ment variability in measuring lung function of the same
individuals still exists.
Among the 14 PEACE centres, we observed an overall
between-instrument variability of 62% for FVC and of
51% for FEV1. Compared to those of other quality control
studies [i.e. the Swiss study on air pollution and lung
diseases in adults (SAPALDIA) (8) and the American Lung
Health Study (LHS) (7,16)], such a variability was the
highest for FVC, and the second highest for FEV1 (Fig. 5).
Nevertheless, excluding the few centres with statistically
significant DFVC and DFEV1 values (i.e. those with an
absolute DFVC and DFEV1 higher than 026 and 022 l,
respectively), the corresponding CV were 51% and 39% in
nine and 11 centres, respectively, thus yielding a better
performance than the LHS (7, 16).
FIG. 1. Plot of individual dierences between FVC measured by local and reference instrument (DFVC) versus their mean in
PEACE study centres. The three central lines refer to the mean DFVC for all PEACE centres, and to the upper and lower
limit of agreement, defined as [mean DFVC  2 standard deviations]. ^ = Amsterdam; *: Athens; &: Berlin; *:
Budapest; +: Cracow; : Hettstedt; ": Katowice; 3: Kuopio; !: Malmo¨; ~: Oslo; ~: Pisa; : Prague; : Teplice;
: Umea˚.
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within-day variability for FVC and FEV1 (i.e. 5%),
according to the 1991 American Thoracic Society (ATS)
statement on lung function testing (17). A variability of
such an extent was also observed in an Italian study on
interlaboratory comparison of spirometers (6). Further-
more, in a study on children (18), mainly devoted to
assessing the best of seven dierent methods for summariz-
ing indices from flow–volume curve, the mean within-
subject coecient of variation, in the first three acceptable
manoeuvres, ranged from 25 to 28% and from 24 to 30%
for FVC and FEV1, respectively. Slightly dierently, Wise
et al. (16), comparing eight potential selection methods for
FEV1 and FVC on data from LHS, observed a within-
subject coecient of variation between two short-term
spirometric sessions of 43% for FVC and 44% for FEV1
[mean values among eight methods of selection for FEV1
and FVC from tables 3 and 4 of reference (16)].
The statistical significance of the dierences between the
local and the portable instrument is also to some extent afunction of the level of correlation between the two
measurements: if the correlation is perfect, even a small
dierence is going to be statistically significant, whereas poor
correlation would lead to much scatter and, hence no
significant dierence could be detected. According to the
deviations reported in Tables 2 and 3 and in Figures 1 and 3,
there is much more scatter in some centres than in others. This
may be due partly to the dierent anthropometric character-
istics of subjects and partly to the type of instrument.
In most PEACE centres a high coecient of correlation
between measurements obtained by the local and the
portable instrument was observed ( 092 in 11 centres
for FVC and  098 in nine centres for FEV1). These results
are consistent with those of Rebuck et al. (19), who
observed a close linear relationship between a handheld
portable and a volume displacement spirometer, when
testing normal subjects and patients suering from ob-
structive and restrictive respiratory diseases.
We have obtained better results than those of Mushtaq
et al. (5), who found considerable variation, reaching
FIG. 2. Mean dierence (in percentage) between FVC measured by local and reference instrument (D%FVC) in PEACE
study centres. Am: Amsterdam; At: Athens; Be: Berlin; Bu: Budapest; Cr: Cracow; He: Hettstedt; Ka: Katowice; Ku:
Kuopio; Ma: Malmo¨; Os: Oslo; Pi: Pisa; Pr: Prague; Te: Teplice; Um: Umea˚.
TABLE 3. Mean values of FEV1 (l) measured by local and portable instruments in PEACE study centres, and mean values of
the dierence (D) (l) between the observed values
Local Portable D
Laboratory n Mean SD Mean SD Mean SD P(1) P(2)
Amsterdam 10 433 064 411 057 024 011 001 041
Athens 11 385 070 372 058 019 020 023 049
Berlin 11 382 085 368 084 015 010 013 049
Budapest 10 323 079 377 074 7055 052 0004 006
Cracow 11 183 024 205 030 7022 013 50001 002
Hettstedt 14 225 052 203 047 024 010 50001 0008
Katowice 10 367 105 351 099 018 016 004 068
Kuopio 13 358 087 365 091 7009 007 005 064
Malmo¨ 15 375 083 372 082 009 007 020 083
Oslo(3) 10 291 094 281 098 017 011 001 053
Pisa 12 479 087 404 071 075 025 50001 50001
Prague 10 372 060 339 057 033 022 0002 009
Teplice 13 326 079 320 072 005 006 005 079
Umea˚ 8 353 097 354 092 7013 009 048 094
All 158 345 106 336 096 010 034 50001 009
(1)By Friedman test.
(2) By ANOVA, accounting for sex, age, height (in Cracow only for age and height, since all subjects were males).
(3) One subject in Oslo has missing data for age, height, and sex.
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FIG. 3. Plot of individual dierences between FEV1 measured by local and reference instrument (DFEV1) versus their mean
in PEACE study centres. The three central lines refer to the mean DFEV1 for all PEACE centres, and to the upper and lower
limit of agreement, defined as [mean DFEV1  2 standard deviations].^: Amsterdam;*: Athens;&: Berlin;*: Budapest;
+: Cracow; : Hettstedt; ": Katowice; 3: Kuopio; !: Malmo¨; ~: Oslo; ~: Pisa; : Prague; : Teplice; : Umea˚.
200 G. VIEGI ET AL.statistical significance, in lung function indices of normal
subjects investigated with the instruments of 23 laboratories
in the West Midlands of the U.K. In one of the three
subjects examined, they observed a range of 39–50 l for
FEV1 and of 52–63 l for FVC.
The PEACE quality control protocol was quite simple
and based on the assumption that the portable spirometer
(i.e. the ‘reference’ for the present study) worked well on all
occasions. It was aimed only at checking interlaboratory
variability of lung function indices, while it was not aimed
at validating either the spirometer/pneumotachograph
systems used in the various centres or the adequacy of the
Micro Medical device as a ‘reference’. As the comparison
between the local and the reference instrument was only
one, repeatability data were not collected and within-
instrument variability was not evaluated. Therefore, it was
not possible to check if part of the between-instrument
variability was due to the within-instrument variability of
both the reference and the local instrument. Nevertheless,
such a protocol fits with the limited use of lung function
data in the PEACE study. Indeed, spirometry wasoriginally unplanned in the PEACE core project and lung
function data were not supposed to be pooled and analysed
centrally, but to be used locally for further characterization
of symptomatic subjects participating in the panel study.
Indeed, Ku¨nzli et al. (8) were able to perform three
quality control studies on variability of FVC and FEV1 due
to technician, team, device and subject in the eight centres
of the SAPALDIA study. They found no statistically
significant eect of technician nor team on FVC and FEV1
variability. However, they disclosed a significant reduction
of FVC values (10%) due to one device, for which further
investigations revealed potential hardware and software
sources of error which are not recognizable even by trained
technicians, during routine checks. Thus, these authors, in
addition to published guidelines for pulmonary laboratories
(20), recommended software adaptations that enhance the
technician’s attempt at accurate unbiased assessment.
The simple protocol of comparison used in the PEACE
study led to a practical change. We disclosed a systematic
trend of the pneumotacograph used in the Pediatric
Pulmonary Department of the University of Pisa to yield
FIG. 4. Mean dierence (in percentage) between FEV1 measured by local and reference instrument (D%FEV1) in PEACE
study centres. Am: Amsterdam; At: Athens; Be: Berlin; Bu: Budapest; Cr: Cracow; He: Hettstedt; Ka: Katowice; Ku:
Kuopio; Ma: Malmo¨; Os: Oslo; Pi: Pisa; Pr: Prague; Te: Teplice; Um: Umea˚.
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according to the study procedure (13), after a check from
the manufacturer’s technician who was unable to uncover
the cause of this systematic trend, to recommend the use ofTABLE 4. Coecient of variation of FVC and FEV1 measured
FVC
Laboratory n CV%
Amsterdam 10 33
Athens 11 64
Berlin 11 37
Budapest 10 91
Cracow 11 100
Hettstedt (1) 13 67
Katowice 10 51
Kuopio 13 35
Malmo¨ 15 34
Oslo 10 90
Pisa 12 116
Prague 10 52
Teplice 13 52
Umea˚ 8 55
All 157 62
(1)One subject in Hettstedt had missing data for FVC measuremthe local reference equations instead of the common
Zapletal’s predictions (14) which were clearly unsuitable.
It let the local investigators (21) improve the precision of
forced expirograms measured with their equipment.by local and portable instrument in PEACE study centres
FEV1
SD n CV% SD
24 10 41 17
39 11 36 35
25 11 29 20
103 10 115 113
45 11 78 44
48 13 79 29
44 10 35 25
41 13 17 12
33 15 16 12
79 10 47 40
53 12 119 32
22 10 66 49
50 13 20 14
49 8 27 20
55 157 51 51
ent by portable spirometer.
FIG. 5. Within-subject variability of FVC and FEV1 in
the PEACE study compared to other studies.&: PEACE
study; &: LHS-Enright: mean values between males and
females from table 8 of reference (7); : LHS-Wise: mean
values among eight methods of selection for FEV1and
FVC from tables 3 and 4 of reference (16); :
SAPALDIA: mean values over a series of eight tests
assessed by one technician and eight dierent devices
(except that with software error) from table 3 of reference
(8).
202 G. VIEGI ET AL.Another example of a quality control program within
the framework of a multicentre study is that of Enright et
al. (7), which allowed the short-term intra-individual FEV1
variability during the LHS to be minimized. In this study,
a coecient of variation of 58% for FEV1 and of 55%
for FVC was observed [mean values between males
and females from table 8 of reference (7)]. The authors
ascribed this result to more stringent quality control
procedures implemented in the LHS. In particular, a basic
improvement was obtained using a software which pro-
vided an on-line indication of unacceptable manoeuvres
and poor reproducible Peak Expiratory Flow rate, FEV1
and FVC.
On the whole, according to both the European SAPAL-
DIA (8) and the American LHS (7) experience, the
magnitude of the within-subject between-session variability
may be kept lower than 6% by observing continuous
quality control procedures.
Nevertheless, a recent study by Linn et al. (22), designed
to minimize variation in instrument-related data obtained
in a multiyear longitudinal study of lung function in 12
communities, through multiple calibration (syringes with
electronic readouts, water-displacement device, electronic
frequency counter), revealed variations in spirometers
which may limit the reliability of epidemiological findings,
even when these spirometers meet ATS specifications.
In conclusion, our study points out the importance of
performing interlaboratory comparisons as quality control
procedures prior to beginning a multicentre study (23), and
supports the need for the manufacturers to extend the
accuracy and precision performances of their instruments
beyond the scientific societies’ recommendations, especially
for quality control software.Acknowledgments
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